- Home
- OM vs HRTX Comparison
OM vs HRTX Comparison
Compare OM & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OM
- HRTX
- Stock Information
- Founded
- OM 2003
- HRTX 1983
- Country
- OM United States
- HRTX United States
- Employees
- OM N/A
- HRTX N/A
- Industry
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- OM Health Care
- HRTX Health Care
- Exchange
- OM Nasdaq
- HRTX Nasdaq
- Market Cap
- OM 305.5M
- HRTX 325.0M
- IPO Year
- OM 2020
- HRTX 1987
- Fundamental
- Price
- OM $17.76
- HRTX $1.93
- Analyst Decision
- OM Buy
- HRTX Strong Buy
- Analyst Count
- OM 2
- HRTX 2
- Target Price
- OM $33.00
- HRTX $5.50
- AVG Volume (30 Days)
- OM 267.6K
- HRTX 2.1M
- Earning Date
- OM 05-07-2025
- HRTX 05-06-2025
- Dividend Yield
- OM N/A
- HRTX N/A
- EPS Growth
- OM N/A
- HRTX N/A
- EPS
- OM N/A
- HRTX N/A
- Revenue
- OM $115,273,000.00
- HRTX $148,518,000.00
- Revenue This Year
- OM $10.80
- HRTX $12.60
- Revenue Next Year
- OM $11.99
- HRTX $13.66
- P/E Ratio
- OM N/A
- HRTX N/A
- Revenue Growth
- OM N/A
- HRTX 12.43
- 52 Week Low
- OM $5.85
- HRTX $1.04
- 52 Week High
- OM $72.60
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- OM 56.88
- HRTX 45.93
- Support Level
- OM $16.73
- HRTX $1.82
- Resistance Level
- OM $19.90
- HRTX $1.93
- Average True Range (ATR)
- OM 1.63
- HRTX 0.11
- MACD
- OM -0.28
- HRTX -0.00
- Stochastic Oscillator
- OM 32.06
- HRTX 56.76
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.